George K. Anagnostopoulos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
George K. Anagnostopoulos has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Dimitrios Arvanitidis
Departments of Gastroenterology and
7 shared publicationsGeorge Margantinis
Departments of Gastroenterology and
7 shared publicationsPanagiotis Kostopoulos
Departments of Gastroenterology and
7 shared publicationsStavros Tsiakos
Departments of Gastroenterology and
6 shared publicationsGeorge Sakorafas
Gastroenterology Clinic , and Departments of ‡Surgery and §Oncology, 251 Hellenic Air Force and Veterans General Hospital, and †Pathology Department and ¶Gastroenterology Clinic, University Hospital of Ioannina Medical School, Athens, Greece
3 shared publicationsDimitrios Stefanou
Pathology Department
2 shared publications
Latest Publications
- 3 April 2008
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 23 (4) , 626-631
Immunohistochemical expression of cell‐cycle proteins in gastric precancerous lesions
Background: The early indicator for the subject predisposed to gastric cancer is abnormal proliferation of gastric epithelial cells, such as atrophic gastritis (AG), intestinal metaplasia (IM), and dysplasia, which have been considered as precancerous lesions of gastric cancer. To determine whether p53 protein, cyclins D1, and D3, and p27kip1 play a role in the carcinogenesis pathway of gastric cancer, we performed an immunohistochemical study of their expression in gastric precancerous lesions.Methods: A total of 1 45 endoscopic gastric biopsy specimens of AG, IM, and gastric dysplasia were studied. These molecular markers were localized by immunohistochemistry.Results: P53 was expressed in 15% of cases with gastric dysplasia and not in the pre‐dysplastic stages of the gastric mucosa. All cases were concerning high‐grade dysplasia. Cyclin D1 protein was almost undetectable in the precancerous lesions of gastric cancer. Cyclin D3 protein overexpression was seen in 10% of biopsies with IM, and 50% of biopsies with gastric dysplasia. High expression of p27kip1 protein was demonstrated in all cases of chronic gastritis. As atrophy, IM, and dysplasia develop, expression of p27kip1 protein is suppressed. In total, 15% of dysplastic cases showed no expression of p27kip1 protein.Conclusions: (i) P53 mutation must be a late event during the development of gastric cancer. (ii) Cyclin D1 protein overexpression may not play a role in the progression from normal to neoplastic gastric mucosa, while overexpression of cyclin D3 is an earlier event during gastric carcinogenesis, and its role must be further evaluated. (iii) Reduced expression of p27kip1 is a rather early event in gastric tumorigenesis, before dysplastic changes occur.
- 3 April 2008
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 23 (4) , 626-631
Immunohistochemical expression of cell‐cycle proteins in gastric precancerous lesions
Background: The early indicator for the subject predisposed to gastric cancer is abnormal proliferation of gastric epithelial cells, such as atrophic gastritis (AG), intestinal metaplasia (IM), and dysplasia, which have been considered as precancerous lesions of gastric cancer. To determine whether p53 protein, cyclins D1, and D3, and p27kip1 play a role in the carcinogenesis pathway of gastric cancer, we performed an immunohistochemical study of their expression in gastric precancerous lesions.Methods: A total of 1 45 endoscopic gastric biopsy specimens of AG, IM, and gastric dysplasia were studied. These molecular markers were localized by immunohistochemistry.Results: P53 was expressed in 15% of cases with gastric dysplasia and not in the pre‐dysplastic stages of the gastric mucosa. All cases were concerning high‐grade dysplasia. Cyclin D1 protein was almost undetectable in the precancerous lesions of gastric cancer. Cyclin D3 protein overexpression was seen in 10% of biopsies with IM, and 50% of biopsies with gastric dysplasia. High expression of p27kip1 protein was demonstrated in all cases of chronic gastritis. As atrophy, IM, and dysplasia develop, expression of p27kip1 protein is suppressed. In total, 15% of dysplastic cases showed no expression of p27kip1 protein.Conclusions: (i) P53 mutation must be a late event during the development of gastric cancer. (ii) Cyclin D1 protein overexpression may not play a role in the progression from normal to neoplastic gastric mucosa, while overexpression of cyclin D3 is an earlier event during gastric carcinogenesis, and its role must be further evaluated. (iii) Reduced expression of p27kip1 is a rather early event in gastric tumorigenesis, before dysplastic changes occur.
- 14 December 2007
- Vol. 70 (3) , 285-9
Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study.
Reduced Bax protein expression has been shown to be a negative prognostic factor in patients with breast, ovarian, colorectal, esophageal and pancreatic cancer. Our aim was to immunohistochemically study Bax protein expression in gastric carcinomas and correlate its expression with clinicopathological parameters and prognosis. Immunohistochemistry was performed, using a monoclonal antibody against bax, in paraffin-embedded tumor specimens from 47 cases of gastric cancer. Positive staining for the Bax protein was found in 20/47 (42.4%) adenocarcinomas examined. Negative Bax protein expression in tumour cells was correlated with lymph node metastasis (P < 0.05), and degree of differentiation (p < 0.05). Univariate analysis showed that the variables with a significant negative impact on survival were: high TNM tumour stage, depth of penetration in the gastric wall, lymph node involvement, and Bax protein expression. Multivariate analysis showed that the only variable with an impact on survival was Bax protein expression (p < 0.05, Relative Risk: 3.34). Kaplan-Meier curves showed that the 5-year survival was 36.8% in cases with positive compared with 16% in cases with negative Bax protein expression (p = 0.0427). Negative Bax expression in gastric cancer is associated with de-differentiation, lymph node metastases, and poor clinical prognosis. Bax protein expression might play an important role in the development and phenotypic differentiation of gastric carcinomas and tumor progression.
- 14 December 2007
- Vol. 70 (3) , 285-9
Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study.
Reduced Bax protein expression has been shown to be a negative prognostic factor in patients with breast, ovarian, colorectal, esophageal and pancreatic cancer. Our aim was to immunohistochemically study Bax protein expression in gastric carcinomas and correlate its expression with clinicopathological parameters and prognosis. Immunohistochemistry was performed, using a monoclonal antibody against bax, in paraffin-embedded tumor specimens from 47 cases of gastric cancer. Positive staining for the Bax protein was found in 20/47 (42.4%) adenocarcinomas examined. Negative Bax protein expression in tumour cells was correlated with lymph node metastasis (P < 0.05), and degree of differentiation (p < 0.05). Univariate analysis showed that the variables with a significant negative impact on survival were: high TNM tumour stage, depth of penetration in the gastric wall, lymph node involvement, and Bax protein expression. Multivariate analysis showed that the only variable with an impact on survival was Bax protein expression (p < 0.05, Relative Risk: 3.34). Kaplan-Meier curves showed that the 5-year survival was 36.8% in cases with positive compared with 16% in cases with negative Bax protein expression (p = 0.0427). Negative Bax expression in gastric cancer is associated with de-differentiation, lymph node metastases, and poor clinical prognosis. Bax protein expression might play an important role in the development and phenotypic differentiation of gastric carcinomas and tumor progression.
- 27 October 2006
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (12) , 1863-1864
Postinfantile giant‐cell hepatitis associated with ulcerative colitis and autoimmune hepatitis
Postinfantile giant cell hepatitis (PGCH) is rare. It is characterized by the presence of multinucleated giant cells in liver biopsy, and although it has been associated with several etiological agents, in many cases its etiology remains unclear. The case is presented herein of an adult woman with PGCH in the setting of ulcerative colitis and autoimmune hepatitis. The presence of autoimmune hepatitis in the patient is consistent and supports the autoimmune pathogenesis of PGCH in a subgroup of patients. Furthermore, this finding, along with others, suggests that PGCH may be included in the list of hepatic complications of inflammatory bowel disease.
- 27 October 2006
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (12) , 1863-1864
Postinfantile giant‐cell hepatitis associated with ulcerative colitis and autoimmune hepatitis
Postinfantile giant cell hepatitis (PGCH) is rare. It is characterized by the presence of multinucleated giant cells in liver biopsy, and although it has been associated with several etiological agents, in many cases its etiology remains unclear. The case is presented herein of an adult woman with PGCH in the setting of ulcerative colitis and autoimmune hepatitis. The presence of autoimmune hepatitis in the patient is consistent and supports the autoimmune pathogenesis of PGCH in a subgroup of patients. Furthermore, this finding, along with others, suggests that PGCH may be included in the list of hepatic complications of inflammatory bowel disease.
- 11 January 2006
- Vol. 7 (1) , 47-50
Squamous cell carcinoma of the pancreas: report of a case and review of the literature.
Although, squamous metaplasia of the ductal columnar cells can be observed during periods of inflammation, squamous cell pancreatic carcinoma is an extremely rare tumour. We present the case of a 72-year-old man who presented to our hospital with painless obstructive jaundice. After careful and adequate staging investigations that revealed a malignant mass in the head of pancreas he underwent a laparotomy which revealed an inoperable pancreatic cancer. Palliative bypass procedure was done. The biopsy specimens revealed a squamous cell cancer. Pure squamous cell carcinoma of the pancreas is a very rare malignancy. In most cases it is not possible to make a pre-operative histological diagnosis and curative resection is unlikely because of dissemination at the time of initial diagnosis or laparotomy.
- 11 January 2006
- Vol. 7 (1) , 47-50
Squamous cell carcinoma of the pancreas: report of a case and review of the literature.
Although, squamous metaplasia of the ductal columnar cells can be observed during periods of inflammation, squamous cell pancreatic carcinoma is an extremely rare tumour. We present the case of a 72-year-old man who presented to our hospital with painless obstructive jaundice. After careful and adequate staging investigations that revealed a malignant mass in the head of pancreas he underwent a laparotomy which revealed an inoperable pancreatic cancer. Palliative bypass procedure was done. The biopsy specimens revealed a squamous cell cancer. Pure squamous cell carcinoma of the pancreas is a very rare malignancy. In most cases it is not possible to make a pre-operative histological diagnosis and curative resection is unlikely because of dissemination at the time of initial diagnosis or laparotomy.
- Open Access
- 1 January 2006
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (28) , 4586-4587
Diagnosis of autoimmune gastritis by high resolution magnification endoscopy
Endoscopic visualisation of gastric atrophy is usually not feasible with conventional endoscopy. Magnifying endoscopy is helpful to analyze the subepithelial microvascular architecture as well as the mucosal surface microstructure without tissue biopsy. Using this technique we were able to describe the normal gastric microvasculature pattern and we also identified characteristic patterns in two cases of autoimmune atrophic gastritis.
- 1 January 2006
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (28) , 4586-4587
Open AccessDiagnosis of autoimmune gastritis by high resolution magnification endoscopy
Endoscopic visualisation of gastric atrophy is usually not feasible with conventional endoscopy. Magnifying endoscopy is helpful to analyze the subepithelial microvascular architecture as well as the mucosal surface microstructure without tissue biopsy. Using this technique we were able to describe the normal gastric microvasculature pattern and we also identified characteristic patterns in two cases of autoimmune atrophic gastritis.
- 12 October 2005
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 20 (11) , 1674-1678
Bax and Bcl‐2 protein expression in gastric precancerous lesions: Immunohistochemical study
Background and Aims: Bcl‐2 protein prolongs cell survival in the face of classical apoptotic stimuli, and is considered to be a suppressor of apoptosis. Bax plays a key role in apoptosis by accelerating cell death after an apoptotic stimulus. The aim of our study was to determine the roles of the Bax proapoptotic gene and the Bcl‐2 antiapoptotic gene in the carcinogenesis of gastric cancer.Methods: One hundred and forty‐five gastric biopsy specimens of chronic gastritis, atrophic gastritis, intestinal metaplasia and gastric dysplasia were studied. Using immunohistochemical methods, Bax and Bcl‐2 protein expression was observed.Results: Bax was expressed in epithelial cells in all cases of chronic gastritis. Bax was not detected in 26% of specimens of atrophic gastritis. As intestinal metaplasia develops, Bax is further suppressed. In biopsy samples with dysplasia, Bax expression was demonstrated only in 12% of biopsy samples. Although Bcl‐2 protein was not detected in chronic gastritis, aberrant expression was found in gastric epithelial intestinal metaplasia and dysplasia.Conclusions: The suppression of Bax and overexpression of Bcl‐2 protein is an early event in gastric tumorigenesis, before gastric dysplastic changes occur.
- 12 October 2005
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 20 (11) , 1674-1678
Bax and Bcl‐2 protein expression in gastric precancerous lesions: Immunohistochemical study
Background and Aims: Bcl‐2 protein prolongs cell survival in the face of classical apoptotic stimuli, and is considered to be a suppressor of apoptosis. Bax plays a key role in apoptosis by accelerating cell death after an apoptotic stimulus. The aim of our study was to determine the roles of the Bax proapoptotic gene and the Bcl‐2 antiapoptotic gene in the carcinogenesis of gastric cancer.Methods: One hundred and forty‐five gastric biopsy specimens of chronic gastritis, atrophic gastritis, intestinal metaplasia and gastric dysplasia were studied. Using immunohistochemical methods, Bax and Bcl‐2 protein expression was observed.Results: Bax was expressed in epithelial cells in all cases of chronic gastritis. Bax was not detected in 26% of specimens of atrophic gastritis. As intestinal metaplasia develops, Bax is further suppressed. In biopsy samples with dysplasia, Bax expression was demonstrated only in 12% of biopsy samples. Although Bcl‐2 protein was not detected in chronic gastritis, aberrant expression was found in gastric epithelial intestinal metaplasia and dysplasia.Conclusions: The suppression of Bax and overexpression of Bcl‐2 protein is an early event in gastric tumorigenesis, before gastric dysplastic changes occur.
- 22 February 2005
- Published by Wiley in Journal of Surgical Oncology
- Vol. 89 (4) , 273-275
Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF
- 22 February 2005
- Published by Wiley in Journal of Surgical Oncology
- Vol. 89 (4) , 273-275
Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF
- Open Access
- 5 October 2004
- Published by Oxford University Press (OUP)
- Vol. 80 (948) , 580
Tuberous sclerosis associated with giant bilateral bleeding angiomyolipomas
A 29 year old woman with tuberous sclerosis presented with diffuse abdominal pain, gross haematuria, and hypotension. At the age of 22 the patient had been admitted to our hospital with acute upper abdominal pain and gross haematuria. Physical examination had revealed bilateral massive abdominal masses with no tenderness. Computed tomography had confirmed the presence of giant bilateral renal masses with the typical appearance of an angiomyolipoma, and a huge retroperitoneal haematoma extending to the pelvis and the left side of the abdomen (fig 1). After arterial embolisation, left radical nephrectomy was performed. The pathological diagnosis was angiomyolipoma without malignant findings, and the patient was discharged two weeks after the operation (fig 2).
- 5 October 2004
- Published by Oxford University Press (OUP)
- Vol. 80 (948) , 580
Open AccessTuberous sclerosis associated with giant bilateral bleeding angiomyolipomas
A 29 year old woman with tuberous sclerosis presented with diffuse abdominal pain, gross haematuria, and hypotension. At the age of 22 the patient had been admitted to our hospital with acute upper abdominal pain and gross haematuria. Physical examination had revealed bilateral massive abdominal masses with no tenderness. Computed tomography had confirmed the presence of giant bilateral renal masses with the typical appearance of an angiomyolipoma, and a huge retroperitoneal haematoma extending to the pelvis and the left side of the abdomen (fig 1). After arterial embolisation, left radical nephrectomy was performed. The pathological diagnosis was angiomyolipoma without malignant findings, and the patient was discharged two weeks after the operation (fig 2).
- 1 October 2004
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 49 (10) , 1677-1680
CASE REPORT: Inflammatory Fibroid Polyp of the Small Intestine Causing Intussusception: A Report of Two Cases
- 1 October 2004
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 49 (10) , 1677-1680
CASE REPORT: Inflammatory Fibroid Polyp of the Small Intestine Causing Intussusception: A Report of Two Cases
- 8 September 2004
- Published by Oxford University Press (OUP)
- Vol. 80 (947) , 526
Cholecystocolic fistula demonstrated by endoscopic retrograde cholangiopancreatography
- 8 September 2004
- Published by Oxford University Press (OUP)
- Vol. 80 (947) , 526
Cholecystocolic fistula demonstrated by endoscopic retrograde cholangiopancreatography